IT-12 WT1 PEPTIDE VACCINATION AGAINST GLIOMAS; COMBINATION WITH TEMOZOLOMIDE, BIOMARKERS AND IMMUNOLOGICAL RESPONSE

We report the long-term outcome on phase I study of combined WT1 peptide vaccination/temozolomide against newly diagnosed glioblastomas. Immunological biomarker and response were investigated in trials targeting newly diagnosed and recurrent cases. The survival analysis was performed on 7 patients i...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autori: Hashimoto, Naoya, Chiba, Yasuyoshi, Kijima, Noriyuki, Arita, Hideyuki, Kinoshita, Manabu, Kagawa, Naoki, Tsuboi, Akihiro, Oka, Yoshihiro, Oji, Yusuke, Sugiyama, Haruo, Yoshimine, Toshiki
Format: Artigo
Jezik:Inglês
Izdano: Oxford University Press 2014
Teme:
Abstracts
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4218228/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/nou258.10
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items